MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MP-23-0015012
Riemann Labs Private Limited - pharma in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹9.75 Cr
▲ 37% YoY
Net profit · FY 2025
₹31.35 Lakh
Net margin 3.2%
EBITDA · FY 2025
₹1.25 Cr
EBITDA margin 12.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹7.01 Lakh
Issued & subscribed
Open charges
₹6.15 Cr
Secured borrowings
Company age
27 yrs
Est. 1999
Directors on board
4
As per MCA filings
About Riemann Labs Private Limited
Data last updated:
Riemann Labs Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 March 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP1999PTC013404. Its GSTIN is 23AABCR8666F1ZA (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7.01 Lakh. It is led by directors including Neeraj Bhatia and Rajesh Bhatia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Indore, Madhya Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.75 Cr, a growth of 37% compared to the previous year. For the same year it recorded a net profit of ₹31.35 Lakh (net margin 3.2%) and EBITDA of ₹1.25 Cr (EBITDA margin 12.8%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 11% over five years.
As per MCA filings, the company has open charges of ₹6.15 Cr on record. Court records list 2 cases involving the company, including 1 filed against it; 1 case is pending.
Riemann Labs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0015012). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website riemannlab.com.
Company Details of Riemann Labs Private Limited
CIN U24232MP1999PTC013404
Registration Number 013404
Incorporation Date 18 March 1999
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MP-23-0015012
Recognitions & Rankings of Riemann Labs
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressSurvey No. 175/2/3, Gram – Mundla Dosdar Bhicholi Hapsi, Indore, Madhya Pradesh, India – 452016
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Riemann Labs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Riemann Labs Private Limited
The main business activity of Riemann Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Riemann Labs Private Limited FY 2025 filings available
Riemann Labs Private Limited reported revenue of ₹9.75 Cr (up 37% YoY) for FY 2025.
Revenue · FY 2025
₹9.75 Cr ▲ 37%
Net profit · FY 2025
₹31.35 Lakh margin 3.2%
EBITDA · FY 2025
₹1.25 Cr margin 12.8%
Compounded Annual Growth Rate (CAGR) of Riemann Labs Private Limited
Revenue CAGR growth
1 year
▲ 37%
3 years · compounded
▲ 1%
5 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▲ 202%
3 years · compounded
▲ 36%
5 years · compounded
▲ 27%
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 37% growth in the latest year. EBITDA rose 202% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Riemann Labs Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.25 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹31.35 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Riemann Labs Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Riemann Labs are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Riemann Labs Private Limited
Riemann Labs has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neeraj Bhatia | Director | 26 May 2018 | 8 Years 4 Months | Current |
| Rajesh Bhatia | Director | 18 Mar 1999 | 27 Years 7 Months | Current |
| Navin Bhatia | Director | 18 Mar 1999 | 27 Years 7 Months | Current |
| Chandan Bhatia | Director | 18 Mar 1999 | 27 Years 7 Months | Current |
Peer Comparison of Riemann Labs Private Limited
Riemann Labs Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Verdin Health Care (OPC) Private Limited | ₹9.85 Cr (FY 2025) | •••• | •••• | 151.0% | •••• | Yavatmal, Maharashtra, India |
| Brio Bliss Life Science Private Limited | ₹9.84 Cr (FY 2021) | •••• | •••• | -35.0% | •••• | Chennai, Tamil Nadu, India |
| Kenil Healthcare Private Limited | ₹9.84 Cr (FY 2025) | •••• | •••• | 162.0% | •••• | Mehsana, Gujarat, India |
| Alps Life Sciences Private Limited | ₹9.83 Cr (FY 2022) | •••• | •••• | 29.0% | •••• | New Delhi, Delhi, India |
| Carewin Pharmaceuticals (Gujarat) Private Limited | ₹9.77 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Ahmedabad, Gujarat, India |
| Riemann Labs Private Limited this company | ₹9.75 Cr (FY 2025) | •••• | •••• | 37.0% | •••• | Indore, Madhya Pradesh, India |
| Foncer Pharma Private Limited | ₹9.73 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Nagpur, Maharashtra, India |
| Mcneil and Argus Pharmaceuticals Limited | ₹9.73 Cr (FY 2024) | •••• | •••• | -59.0% | •••• | Haryana, India |
| Akisab Trading Limited | ₹9.73 Cr (FY 2025) | •••• | •••• | 29.0% | •••• | Mumbai, Maharashtra, India |
| Shree Radhey Gobind International Pharmaceuticals Private Limited | ₹9.73 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Delhi, India |
| Labinduss Limited | ₹9.73 Cr (FY 2025) | •••• | •••• | 27.0% | •••• | Palghat, Kerala, India |
Peers are the five companies nearest above and the five nearest below Riemann Labs by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Riemann Labs Private Limited
Riemann Labs Private Limited is audited by SUNIL CHANDRA GOYAL & CO for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SUNIL CHANDRA GOYAL & CO | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Riemann Labs Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Riemann Labs Private Limited
Open charges
₹6.15 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Mar 2024 | Sidbi | ₹1.02 Cr | Open |
| 08 Oct 2021 | Others | ₹5.13 Cr | Open |
Total charge records: 2 View all charges
Legal Cases of Riemann Labs Private Limited
Riemann Labs Private Limited has 2 court cases on record: 1 filed against it, 1 where it is another party. 1 case is pending and 1 is disposed. Status as checked between 02 Oct 2026 and 04 Oct 2026.
Total cases
2
Filed against the company
1
Pending
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
| District courts | 1 | 1 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Indore, Madhya Pradesh | Court case (UN CR) | Filed against the company by an individual | Pending |
| High Court of Gujarat | Special civil application | Company is another party | Disposed |
Premium access
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Riemann Labs Private Limited
Riemann Labs Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 12 overdue payments to 9 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 9)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| Durrant Packagers (India ) Pvt Ltd | •••• | •••• | •••• |
| H.M. Shah & Company | •••• | •••• | •••• |
| Arpita Enterprises | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Premium access
Full MSME payment history
Every supplier, amount and due date from all 2 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Riemann Labs Private Limited
Employment history and EPFO contributions of people linked to Riemann Labs.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Riemann Labs Private Limited
Riemann Labs Private Limited has 5 board changes on record since 1999: 4 appointments and 1 cessation. The latest: Neeraj Bhatia ceased to be Additional Director on 30 Sep 2018.
AGM
Riemann Labs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Riemann Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Charges
A charge with Others of Rs. 512.50 Lakh registered on 08 Oct 2021 with Charge ID 100488019 was modified on 26 Jul 2024.
Charges
A charge with Sidbi amounted to Rs. 102.00 Lakh with Charge ID 100886843 was registered on 22 Mar 2024.
Charges
A charge with Others amounted to Rs. 512.50 Lakh with Charge ID 100488019 was registered on 08 Oct 2021.
Ceased
Neeraj Bhatia ceased to be Additional Director.
Appointed
Neeraj Bhatia was appointed as Director.
Appointed
Chandan Bhatia was appointed as Director.
Appointed
Navin Bhatia was appointed as Director.
Appointed
Rajesh Bhatia was appointed as Director.
Incorporation
18 Mar 1999
Riemann Labs Private Limited was registered on 18 Mar 1999 with Roc Gwalior & aged 27 years 7 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Riemann Labs Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Riemann Labs Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Riemann Labs Private Limited
Riemann Labs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AABCR8666F1ZA | Madhya Pradesh | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Riemann Labs Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Riemann Labs Private Limited
Riemann Labs is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 March 1999 (27+ years old) and is registered under CIN U24232MP1999PTC013404.
Riemann Labs reported revenue of ₹9.75 Cr for FY 2025 (up 37% YoY).
Riemann Labs has 4 current directors:
- Neeraj Bhatia - Director
- Rajesh Bhatia - Director
- Navin Bhatia - Director
- Chandan Bhatia - Director
Riemann Labs reported a net profit of ₹31.35 Lakh (net margin 3.2%) and EBITDA of ₹1.25 Cr (EBITDA margin 12.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Riemann Labs is 1% over three years and 11% over five years. In the latest year (FY 2025) revenue rose 37%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Riemann Labs is 23AABCR8666F1ZA, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Riemann Labs is U24232MP1999PTC013404. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Riemann Labs has 2 court cases on record: 1 filed against it. 1 is pending. Most are in the high courts.
Riemann Labs was incorporated on 18 March 1999, making it 27+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Riemann Labs by revenue are Verdin Health Care (OPC) Private Limited, Brio Bliss Life Science Private Limited, Kenil Healthcare Private Limited, Alps Life Sciences Private Limited, Carewin Pharmaceuticals (Gujarat) Private Limited and 5 more, all in the Pharma industry (Formulations).
Neeraj Bhatia ceased to be Additional Director on 30 Sep 2018. Neeraj Bhatia was appointed as Director on 26 May 2018. Chandan Bhatia was appointed as Director on 18 Mar 1999. Riemann Labs has 5 board changes on record in total.
Yes, Riemann Labs is registered as a small enterprise under Udyam registration (number: UDYAM-MP-23-0015012).